| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -277.93K | -251.33K | -65.04K | 0.00 |
| EBITDA | -3.68M | -3.40M | -3.89M | -1.82M | -117.32K |
| Net Income | -4.49M | -4.49M | -4.18M | -1.89M | -117.31K |
Balance Sheet | |||||
| Total Assets | 7.70M | 7.70M | 8.00M | 10.45M | 2.09M |
| Cash, Cash Equivalents and Short-Term Investments | 594.90K | 594.90K | 818.01K | 5.75M | 35.55K |
| Total Debt | 2.36M | 2.36M | 592.68K | 0.00 | 288.00K |
| Total Liabilities | 3.28M | 3.28M | 1.30M | 285.42K | 366.15K |
| Stockholders Equity | 4.42M | 4.42M | 6.69M | 10.17M | 1.72M |
Cash Flow | |||||
| Free Cash Flow | -3.27M | -3.52M | -4.86M | -2.11M | -238.81K |
| Operating Cash Flow | -3.01M | -3.01M | -3.49M | -1.60M | -62.16K |
| Investing Cash Flow | -499.47K | -499.47K | -1.44M | -526.67K | -176.65K |
| Financing Cash Flow | 3.30M | 3.30M | -22.51K | 7.85M | 274.36K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | AU$96.03M | -14.85 | -16.49% | ― | ― | -40.28% | |
43 Neutral | AU$326.76M | -2.01 | -45.24% | ― | -12.84% | -29.62% | |
38 Underperform | AU$10.00M | -0.80 | ― | ― | -37.44% | 10.36% | |
34 Underperform | ― | -0.42 | ― | ― | ― | -105.40% |
ChemX Materials Limited has lodged its Appendix 4G and confirmed that its updated corporate governance statement for the financial year ended 30 June 2025 is available on its website, current as of 23 December 2025 and approved by the board. By detailing the extent to which it follows ASX Corporate Governance Council recommendations—such as maintaining a board charter, undertaking checks on directors and executives, and clarifying accountability of the company secretary—the company underscores its compliance with listing rules and provides investors with clearer visibility over its governance framework and oversight practices.
ChemX Materials Limited has released its annual financial statements for the year ended 30 June 2025, confirming its governance, audit and professional advisory arrangements and reiterating its ASX listing details. The disclosure notes that trading in ChemX securities has been suspended on the ASX since 19 December 2024, highlighting an ongoing halt that is significant for shareholders and may affect liquidity and market confidence until resolved.
ChemX Materials Limited has reported that trading in its securities on the Australian Securities Exchange has been suspended since 19 December 2024, as disclosed in its interim report for the half-year ended 31 December 2024. The suspension underscores a period of heightened uncertainty for shareholders and may signal regulatory or operational issues that could affect the company’s near-term liquidity, market visibility and broader standing with investors.
ChemX Materials Limited has announced the approval of Deeds of Company Arrangement (DOCA) for both itself and its subsidiary, HiPurA Pty Ltd, as part of its voluntary administration process. The restructuring aims to stabilize the company’s operations and explore recapitalization opportunities, with creditors expected to receive partial repayments. The company also reported board changes and held a general meeting to update shareholders on the administration process.
ChemX Materials Limited has appointed voluntary administrators due to financial difficulties, including the inability to secure necessary funding and the resignation of its CEO. Consequently, the company’s securities remain suspended from quotation on the ASX. Despite these challenges, ChemX achieved a significant milestone with the granting of a Japanese patent for its HiPurA® HPA process, enhancing its intellectual property portfolio and potentially strengthening its market position in the materials industry.